G Co, a biotechnology company, reported current assets of $1,326.5 million and current liabilities of $484.1 million in 20X3 and in 20X2, current assets of $1,242.0 million and $291.3 million of current liabilities. Therefore, working capital for G Co. increased from 20X2 to 20X3.

Question

Quizplus · Accepted Answer

The Answer of G Co, a biotechnology company, reported current assets of $1,326.5 million and current liabilities of $484.1 million in 20X3 and in 20X2, current assets of $1,242.0 million and $291.3 million of current liabilities. Therefore, working capital for G Co. increased from 20X2 to 20X3.

G Co, a Biotechnology Company, Reported Current Assets of $1,326